Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析

◆英語タイトル:Lee’s Pharmaceutical Holdings Ltd (950) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH184883FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lee’s Pharmaceutical Holdings Ltd (Lee’s Pharmaceutical) is a bio pharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology, ophthalmology, dermatology, and gynecology. Its products are used for therapeutic indications that include cornea ulcer, reduction of bleeding, viral-infected venereal diseases, and other cardiovascular diseases. Lee’s Pharmaceutical offers pipeline products for cardiovascular, oncology related diseases; ophthalmology, dermatology, and ophthalmology are in different preclinical stages. The company works in partnership with other organizations for the development and distribution rights for products across the US, Japan and Europe. It operates through its manufacturing facility located at Hefei City, China. Lee’s Pharmaceutical is headquartered in Hong Kong.

Lee’s Pharmaceutical Holdings Ltd Key Recent Developments

Mar 07,2021: Lee’s Pharmaceutical Announces its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, Receives Clearance to Start Phase 3 Trial as a First-line Treatment of Extensive-stage Small-Cell Lung Cancer
Aug 14,2020: Lee’s Pharm announced 2020 interim results positive profit alert
Jul 09,2020: Lee’s Pharmaceutical Holdings: Voluntary announcement possible Spin-off and Separate Listing Of China Ophthalmology Focus
Feb 03,2020: Lee’s Pharmaceutical Holdings: Voluntary announcement update on business development

This comprehensive SWOT profile of Lee’s Pharmaceutical Holdings Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Lee’s Pharmaceutical Holdings Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Lee’s Pharmaceutical Holdings Ltd – Key Information
Lee’s Pharmaceutical Holdings Ltd – Overview
Lee’s Pharmaceutical Holdings Ltd – Key Employees
Lee’s Pharmaceutical Holdings Ltd – Key Employee Biographies
Lee’s Pharmaceutical Holdings Ltd – Key Operational Heads
Lee’s Pharmaceutical Holdings Ltd – Major Products and Services
Lee’s Pharmaceutical Holdings Ltd – History
Lee’s Pharmaceutical Holdings Ltd – Company Statement
Lee’s Pharmaceutical Holdings Ltd – Locations And Subsidiaries
Lee’s Pharmaceutical Holdings Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Lee’s Pharmaceutical Holdings Ltd – Business Description
Lee’s Pharmaceutical Holdings Ltd – Corporate Strategy
Lee’s Pharmaceutical Holdings Ltd – SWOT Analysis
SWOT Analysis – Overview
Lee’s Pharmaceutical Holdings Ltd – Strengths
Lee’s Pharmaceutical Holdings Ltd – Weaknesses
Lee’s Pharmaceutical Holdings Ltd – Opportunities
Lee’s Pharmaceutical Holdings Ltd – Threats
Lee’s Pharmaceutical Holdings Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Lee’s Pharmaceutical Holdings Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Lee's Pharmaceutical Holdings Ltd, Key Information
Lee's Pharmaceutical Holdings Ltd, Key Ratios
Lee's Pharmaceutical Holdings Ltd, Share Data
Lee's Pharmaceutical Holdings Ltd, Major Products and Services
Lee's Pharmaceutical Holdings Ltd, History
Lee's Pharmaceutical Holdings Ltd, Key Employees
Lee's Pharmaceutical Holdings Ltd, Key Employee Biographies
Lee's Pharmaceutical Holdings Ltd, Key Operational Heads
Lee's Pharmaceutical Holdings Ltd, Other Locations
Lee's Pharmaceutical Holdings Ltd, Subsidiaries
Lee's Pharmaceutical Holdings Ltd, Key Competitors
Lee's Pharmaceutical Holdings Ltd, SWOT Analysis
Lee's Pharmaceutical Holdings Ltd, Ratios based on current share price
Lee's Pharmaceutical Holdings Ltd, Annual Ratios
Lee's Pharmaceutical Holdings Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VirTra Inc (VTSI):企業の財務・戦略的SWOT分析
    VirTra Inc (VTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Agilent Technologies Inc (A)-医療機器分野:企業M&A・提携分析
    Summary Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The …
  • Maruzen Petrochemical Co Ltd:企業の戦略的SWOT分析
    Maruzen Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Octapharma AG:企業の戦略・SWOT・財務情報
    Octapharma AG - Strategy, SWOT and Corporate Finance Report Summary Octapharma AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • DFDS AS (DFDS):企業の財務・戦略的SWOT分析
    DFDS AS (DFDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • FactSet Research Systems Inc. (FDS):企業の財務・戦略的SWOT分析
    FactSet Research Systems Inc. (FDS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Welltower Inc:企業の戦略・SWOT・財務情報
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • CSL Ltd (CSL):製薬・医療:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • Angle Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers …
  • MIS Implants Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary MIS Implants Technologies Ltd (MIS) is a medical device company that offers advanced products and solutions for dental implantology treatment. The company offers products such as superstructures, dental implants, tools and kits, and solutions for oral restoration and health, among others. It …
  • Wilmar International Limited:企業の戦略・SWOT・財務分析
    Wilmar International Limited - Strategy, SWOT and Corporate Finance Report Summary Wilmar International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Immunomedics Inc (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and autoimmune disorders. The company develops its candidates based on its proprietary technol …
  • Fanuc Corp (6954)
    Fanuc Corp (6954) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Skipton Building Society (SBSB):企業の財務・戦略的SWOT分析
    Skipton Building Society (SBSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • China Power Clean Energy Development Co Ltd (735):企業の財務・戦略的SWOT分析
    China Power Clean Energy Development Co Ltd (735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • AIG Asia Pacific Insurance Pte. Ltd.:企業の戦略・SWOT・財務情報
    AIG Asia Pacific Insurance Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AIG Asia Pacific Insurance Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Infant Bacterial Therapeutics AB (IBT B):企業の財務・戦略的SWOT分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops drugs influencing the human infant microbiome to treat rare diseases in premature infants. Its pipeline product candidates include IBP-9414, containing the active substance Lactobacil …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • Nyrstar NV:企業の戦略・SWOT・財務情報
    Nyrstar NV - Strategy, SWOT and Corporate Finance Report Summary Nyrstar NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆